Skip to content

About
News
Clinicians
Patients
Research

Menu

About
News
Clinicians
Patients
Research

Retina Publications

All
Retina
Cornea
AMD
CNV
RVO
DME
ROP
Keratoconus
Dry Eye
Glaucoma

Menu

All
Retina
Cornea
AMD
CNV
RVO
DME
ROP
Keratoconus
Dry Eye
Glaucoma

The Fight Inherited Retinal Blindness! Project: A new treatment outcome and natural history registry for inherited retinal disease

Retina

, (epub)

October 2024

Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice

Ophthalmology and Therapy

September 2024

Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study

Eye

, (epub)

September 2024

One-year anti-VEGF therapy outcomes in diabetic macular edema based on treatment intensity: Data from the FRB! registry

Ophthalmology. Retina

, (epub)

April 2024

European Unmet Needs in the Management of Neovascular Age-Related Macular Degeneration in Daily Practice: Data from the Fight Retinal Blindness! Registry

Ophthalmology Retina

June 2024

Development of a joint set of database parameters for the EU-ROP and Fight Childhood Blindness! ROP Registries

British Journal of Ophthalmology

June 2024

Macular Neovascularization type influence on anti-VEGF intravitreal therapy outcomes in Age-related Macular Degeneration

Ophthalmology. Retina

April 2024

Three-year outcomes of vascular endothelial growth factor inhibitors in naïve branch retinal vein occlusion: Fight Retinal Blindness!

Ophthalmology. Retina

, (epub)

April 2024

Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry

Scientific Reports

, (epub)

March 2024

Twenty-four-month real-life treatment outcomes of polypoidal choroidal vasculopathy versus type 1 macular neovascularization in Caucasians

Clinical and Experimental Ophthalmology

November 2023

Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life Experience

Ophthalmology and Therapy

October 2023

Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry

British Journal of Ophthalmology

June 2023

« Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Next »

Email: ssi.ssr@sydney.edu.au
Phone: (+61) 421 787 808

Level 1, South Block
Sydney Eye Hospital
8 Macquarie Street
Sydney NSW 2000

Follow us

X-twitter Facebook Youtube

Quick links

Contact Us
Donate Now

Contact Us
Donate Now